Illumina announced that it is joining hands with Partners HealthCare to bring new tools for Genetic test reporting using Next Generation Sequencing Data. Partners HealthCare is a non-profit organization founded by Brigham and Women’s Hospital and Massachusetts General Hospital.
Illumina said the new tools will offer medical geneticists and pathologists infrastructure to help interpreting the genetic sequencing data. The new tools will integrate Illumina’s MiSeq System to Partners’ GeneInsight Suite. GeneInSight Suite of tools is developed by Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) and has been used in the clinical setting for analyzing over 24,000 complex genetic tests since 2005.
Basically, the new integrated tools will start at sequencing data from Illumina MiSeq system and link it to BaseSpace cloud computing platform, MyGenome app for iPad®, and local laboratory information system and give the results to the GeneInsight Suite. Illumina hopes that the integration with NGS system will help laboratory personnel to interpret data accurately.
The press release announcing the Illumina’s entry to the personal genetic test space said , Illumina and Partners HealthCare will do a pilot test of the combined MiSeq-GeneInsight solution using a select pilot customers in the clinical testing space. Illumina will also use the GeneInsight Lab application in its CLIA-certified sequencing laboratory for clinical interpretation and reporting. In addition to entering personal genetic testing space, Illumina also introduced rapid Whole Individual Genome Sequencing service (CLIA certified) using its HiSeq 2500 for Clinical Genomics purposses.
Matt Posard, Senior Vice President and General Manager of Illumina’s Translational and Consumer Genomics business, said
Illumina and Partners HealthCare share a vision of better patient care through genomics. This alliance highlights our commitment to a collaborative model that will establish the new standard in NGS clinical-based applications and enable a truly integrated, high-quality solution.
Anne Klibanski, M.D., Chief Academic Officer, Partners HealthCare, said
We expect the collaboration between our organizations to yield significant benefits to our patients, and to patients worldwide. We’re excited about this extraordinary opportunity to work together to improve patient care and equally pleased that Illumina is committed to developing solutions that continue to advance our understanding of human genetics and disease